Korlym and Renal disorder - a phase IV clinical study of FDA data

Summary:

Renal disorder is reported as a side effect among people who take Korlym (mifepristone), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Humalog, and have Cushing's syndrome.

The phase IV clinical study analyzes which people have Renal disorder when taking Korlym. It is created by eHealthMe based on reports of 3,073 people who have side effects when taking Korlym from the FDA, and is updated regularly.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

What is Renal disorder?

Renal disorder (kidney disease) is found to be associated with 1,729 drugs and 1,670 conditions by eHealthMe. Check the latest studies of Renal disorder.

On Jul, 13, 2026

3,073 people reported to have side effects when taking Korlym.
Among them, 19 people (0.62%) have Renal disorder.

Among these 19 people:

How long have people been on Korlym when they have Renal disorder? *

What is the gender of people who have Renal disorder when taking Korlym? *

female: 80 %
male: 20 %

What is the age of people who have Renal disorder when taking Korlym? *

What are other drugs people take besides Korlym? *

What are other side effects people have besides Renal disorder? *

Fatigue (feeling of tiredness): 4 people, 21.05%
Blood Glucose Increased: 3 people, 15.79%
Dyspnea (difficult or laboured breathing): 3 people, 15.79%
Nausea (feeling of having an urge to vomit): 3 people, 15.79%
Blood Potassium Decreased: 3 people, 15.79%
Dizziness: 3 people, 15.79%
Peripheral Swelling: 3 people, 15.79%
Insomnia (sleeplessness): 2 people, 10.53%
Indigestion: 2 people, 10.53%
Communication Disorder (speech and language disorder): 2 people, 10.53%

What are the existing conditions these people have? *

Cushing's Syndrome (obesity, a rounded face, increased fat): 15 people, 78.95%
Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 3 people, 15.79%
Type 2 Diabetes: 2 people, 10.53%
Weight Loss: 1 person, 5.26%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.26%
Hypersensitivity: 1 person, 5.26%
Hyperglycemia (high blood sugar): 1 person, 5.26%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 5.26%
Essential Hypertension (primary hypertension): 1 person, 5.26%
Adrenal Disorder: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Korlym and have Renal disorder?

- Check whether Renal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Korlym:

Korlym (3,078 reports)

Renal disorder treatments and more:

Renal disorder (60,733 reports)

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal disorder:

Renal disorder (1,729 drugs)

Browse all the conditions that are associated with Renal disorder:

Renal disorder (1,670 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mifepristone (the active ingredients of Korlym) and Korlym (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.